WuXi launches $250M fund to invest in life sciences startups
WuXi PharmaTech, a Chinese R&D powerhouse, is launching its second fund. It wants to invest $250 million into healthcare and life sciences startups in the U.S. and China.
WuXi PharmaTech, a Chinese R&D powerhouse, is launching its second fund. It wants to invest $250 million into healthcare and life sciences startups in the U.S. and China.